Target intelligence / Profile preview

DNA within the DNA Topoisomerase II–DNA cleavage complex (TOP2cc) (TOP2cc)

Target
TOP2cc
Molecular classification
Nucleic acid, Protein-DNA complex, Enzyme-substrate complex
01

Overview

DNA within the DNA Topoisomerase II–DNA cleavage complex (TOP2cc) is a transient but essential intermediate formed during the catalytic cycle of Topoisomerase II (TOP2) enzymes, which regulate DNA supercoiling, decatenation, and knotting (Pommier et al., 2016, Nature Reviews Cancer). In this complex, the TOP2 enzyme creates a double-strand break and becomes covalently linked to the 5' phosphate ends of the DNA via a tyrosyl-DNA phosphodiester bond (Deweese & Osheroff, 2009, Nucleic Acids Research). This specific DNA-protein interface is the pharmacological target for "TOP2 poisons," such as etoposide and doxorubicin, which act by stabilizing the cleavage complex and preventing the religation of the DNA strands (Nitiss, 2009, Nature Reviews Cancer). The stabilization of TOP2cc converts a necessary cellular process into a source of persistent double-strand breaks, which are recognized by the cell's DNA damage response machinery, leading to cell cycle arrest and apoptosis (StatPearls, 2023). While highly effective in treating various cancers, including leukemias and solid tumors, targeting this complex carries risks such as cardiotoxicity—often linked to TOP2B in cardiomyocytes—and the potential for secondary malignancies due to chromosomal translocations (Zhang et al., 2012, Nature Medicine).

Other names
TOP2-DNA cleavage complexTopoisomerase II-DNA covalent complexTOP2cc-DNADNA-TOP2 covalent complex
02

Mechanism of action

Stabilization of the transient covalent DNA Topoisomerase II–DNA cleavage complex, which inhibits DNA religation and leads to the accumulation of double-strand breaks (Pommier et al., 2016, Nature Reviews Cancer).

03

Biological functions

DNA replicationTranscriptionChromosome segregationDNA supercoiling regulationDNA decatenation
04

Disease associations

CancerSecondary malignancy
05

Safety considerations

Cardiotoxicity (TOP2B-mediated)Secondary acute myeloid leukemia (t-AML)MyelosuppressionAlopeciaGastrointestinal toxicity
06

Interacting drugs

Etoposide

7 more in the full profile.

07

Biomarkers

TOP2A expressionTOP2B expressionγ-H2AX (gamma-H2AX) phosphorylationTOP2cc levels (ICE assay)

Beyond the preview

Go deeper on DNA within the DNA Topoisomerase II–DNA cleavage complex (TOP2cc) (TOP2cc).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA within the DNA Topoisomerase II–DNA cleavage complex (TOP2cc) (TOP2cc).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call